Nuvigil

On Friday, Cephalon (NASDAQ: CEPH) announced that the U.S. District Court of Delaware ruled in favor of Watson with respect to two patents surrounding Fentora. The Court has yet to rule on the last of the three patents in question. The ruling is sure to stir further anxiety regarding the extent of...